Health Journalism Under the Gun

  • by: |
  • 03/30/2011
I attended an excellent conference at The New York Academy of Sciences Monday entitled Vaccines Under the Gun. The participants were Paul Offit, MD, Dan Thomasch (who argued the Supreme Court case limiting vaccine maker liability) and Trine Tsouderos, Chicago Tribune science and health reporter who spent a year investigating alternative treatments for autism, leading to a series of stories that deemed them risky and unproven and Perri Klass, a pediatrician and author of many books and articles on health, medicine and children.

The major point of discussion was: Why did the media fail so miserably in covering the vaccine-autism link and why was it willing to give junk and pseudo science a platform?

No one answer was provided. However it is clear that the motivations and approach of journalists that perpetuated this false narrative is alive and well. The participants made the following points:

1. Health care journalists limit their focus on conflicts to specific industries and give those ‘experts’ who raise questions about the integrity of companies, who claim links between chemicals and disease and who identify the profit motive as inherently evil are free pass. Here are one recent example: 
FDA Probes Link Between Food Dyes, Kids' Behavior

‎2. Health care journalists ignore all ‘conflicts of interest’ except when it comes to medical product companies. For instance, a story in Reuters claiming if doctors prescribed more generic drugs there would be more compliance and less spent on medications. It was based on a study conducted by CVS and Harvard professors who claimed no financial interest. The authors are: an executive of CVSCaremark, a doctor running CVS Caremark Harvard Partnership for Improving Medication Adherence and another making money doing academic detailing. The authors did not disclose this association or were not required to. Even health care journalists are guilty of this deliberate oversight: Joanne Kenen’s
bio on the Health Journalism blog leaves out her long affiliation with the left-leaning New America Foundation.

3. Health care journalists continue to ignore the body of science in covering a study. The Reuters article is a case in point: The totality of evidence regarding the impact of generic drugs in improving adherence is unclear at best because most studies do not measure the impact of switching to a generic on compliance. Such studies, with rare exception, fail to look at total treatment costs in specific therapeutic areas. Finally, there is a body of evidence demonstrating that “allowing people to use only generic drugs would increase total treatment costs, not reduce them, and would lead to worse outcomes.”

More here.

Similarly, coverage of the food color-ADHD ‘connection’ has ignored several large studies and a European Food Safety Agency review harshly criticizing the small ‘studies’ for the same reasons Wakefield’s MMR-autism ‘research’ was trashed.

More here.

The
following blog post shows how an unbiased journalist would critically cover this story.

All of which leads me to conclude that health care journalists need to be more vigilant in correcting those in the field. There is nothing wrong and indeed much to admire in reporting or coverage with a strong point of view or bias. I don’t think journalists should be penalized for having a particular bent or expressing opinions on most subjects. At the same time it is wrong to apply a double standard on conflicts, (which will be the subject of another post) fail to do a 5 minute search of well-designed studies that have clear endpoints or subject a medical or scientific claims about risks to the scrutiny of clear, replicable evidence. Finally, journalists and headline writers have to stop framing possible associations as causation.  
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog